@article{oai:repository.lib.tottori-u.ac.jp:00007697,
 author = {原田, 智也 and Harada, Tomoya and Inui, Genki and Ishikawa, Hiroki and Kato, Ryohei and Sueda, Yuriko and 舟木, 佳弘 and Funaki, Yoshihiro and 高田, 美樹 and Takata, Miki and 岡崎, 亮太 and Okazaki, Ryota and 森田, 正人 and Morita, Masato and Kitatani, Shin and 山崎, 章 and Yamasaki, Akira and Inui, Genki and Ishikawa, Hiroki and Kato, Ryohei and Sueda, Yuriko and Kitatani, Shin},
 issue = {2},
 journal = {Yonago Acta Medica, Yonago Acta Medica},
 month = {May},
 note = {00575, 03426, 00455, 03616, 02905, 02296, 04358, Background: Allergic bronchopulmonary mycosis (ABPM) occurs with fungi, other than Aspergillus fumigatus. However, the clinical characteristics of ABPM caused by non-Aspergillus species are unspecified. Methods: We retrospectively reviewed all patients with ABPM who visited to our hospital between April 2005 and December 2020. The causative fungi and clinical characteristics were analyzed. Patients were divided into the Aspergillus group and the non-Aspergillus group. Results: Fourteen patients and five patients were included in the Aspergillus group and the non-Aspergillus group, respectively. Compared to the Aspergillus group, the non-Aspergillus group had a significantly low serum immunoglobulin E level and low forced vital capacity. In addition, the non-Aspergillus group had a lower rate of the requirement for oral corticosteroid treatment and a low frequency of recurrence. Conclusion: Patients with non-Aspergillus ABPM had lower type 2 inflammation than did patients with allergic bronchopulmonary aspergillosis.},
 pages = {257--262},
 title = {The Clinical Characteristics of Allergic Bronchopulmonary Mycosis Differ Among Pathogenic Fungi},
 volume = {66},
 year = {2023},
 yomi = {ハラダ, トモヤ and スエダ, ユリコ and フナキ, ヨシヒロ and タカタ, ミキ and オカザキ, リョウタ and モリタ, マサト and ヤマサキ, アキラ and スエダ, ユリコ}
}